Anda Biopharma
PrivateLast Round
Series A
Mar 1, 2025
Company Overview
Anda Biopharma operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in March 2025.
Anda Biopharma is a biotechnology company that develops personalized cancer therapies and vaccines focused on tumor neoantigens using an AI-driven analysis platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anda Biopharma Comparables
Compare Anda Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou Neoantigen Therapeutics Co., Ltd. | 89% | |
| Likang Life Sciences | 88% | |
| WestGene Biopharma | 79% |
For institutional investors. Book with your work email.
Anda Biopharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Anda Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 北京首业君立投资管理有限公司 | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2025
Led by Beijing Shouye Junli Investment Management
For institutional investors. Book with your work email.
Anda Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anda Biopharma's valuation, stock price, and market status.
Is Anda Biopharma a public or private company?
Anda Biopharma is a private company.
What is the current stock price of Anda Biopharma?
Anda Biopharma is a private company, so its shares have no public market price. Caplight tracks Anda Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anda Biopharma worth (valuation)?
Valuation information for Anda Biopharma is not publicly available.
Can I buy Anda Biopharma stock?
Anda Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anda Biopharma's last funding round?
Anda Biopharma's most recent funding round was Series A on March 1, 2025.
Who are the main investors in Anda Biopharma?
Key investors in Anda Biopharma include 北京首业君立投资管理有限公司.
Will Anda Biopharma IPO soon?
No public IPO plans have been announced for Anda Biopharma.
How can I track Anda Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in Anda Biopharma's shares on secondary markets.